Growing antimicrobial resistance is prompting renewed interest in phage therapy, with preliminary data indicating improved outcomes when combined with standard antibiotics.
Apple's latest MacBook Pro upgrade boosts performance with powerful new chips, faster SSDs, and more, making it the ultimate ...
Gregory McVay, group vice president and chief customer officer at Danaher Life Sciences, discusses how automation and AI can ...
Explore how NMIS’ Digital Factory advances circular manufacturing, remanufacturing and digital innovation. Read more.
CEO Abizer Gaslightwala discusses the Company’s strategic partnership with WuXi XDC and its implications for platform ...
Confirmed, pooled, blinded COVID-19 events in the ongoing Phase 3 DECLARATION study of VYD2311 accumulated to date (~ 50% of study progress) can ...
Meet King Bacot. He’s a hot prospect in the NCAA. He’s got a manager and 100,000 followers on Instagram. He’s 15, and making ...
NovogeneAIT Genomics announces its appointment as the designated service provider for the PRECISE-SG100Kproteomics project.
In science, ethical guidelines ensure that research takes place in a way that respects public trust and is conducted ...
University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery ...
With a new model of the brain region essential to memory formation, from cells to whole-brain networks, the team hopes to ...
A three-dimensional experimental system has been developed to study the response to drugs in low-grade glioma, a tumor of the central nervous system that often occurs in children.